|
|
|
|
LEADER |
01453nam a22003615i 4500 |
001 |
000288049 |
005 |
20210908102940.0 |
007 |
cr nn 008mamaa |
008 |
160530s2016 ne | s |||| 0|eng d |
020 |
|
|
|a 9789401775557
|
024 |
7 |
|
|a 10.1007/978-94-017-7555-7
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Progress in Cancer Immunotherapy /
|c edited by Shuren Zhang.
|
250 |
|
|
|a 1st ed. 2016.
|
260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2016.
|
300 |
|
|
|a XII, 283 p. 15 illus., 14 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 909
|
505 |
0 |
|
|a Antibody therapies in cancer -- Biological Response Modifier in Cancer Immunotherapy -- Progress and Development of Therapeutic Cancer Vaccines -- Adoptive Cellular Therapy (ACT) for Cancer Treatment -- Oncolytic Immunotherapy for Treatment of Cancer .
|
650 |
|
0 |
|a Human genetics.
|
650 |
|
0 |
|a Antibodies.
|
650 |
|
0 |
|a Vaccines.
|
650 |
|
0 |
|a Oncology .
|
650 |
1 |
4 |
|a Human Genetics.
|
650 |
2 |
4 |
|a Antibodies.
|
650 |
2 |
4 |
|a Vaccine.
|
650 |
2 |
4 |
|a Oncology.
|
700 |
1 |
|
|a Zhang, Shuren.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|